Lillie James Woodruff has filed 17 insider transactions across 1 company since October 2025.
Most recent transaction: a sale of 721 shares of MapLight Therapeutics, Inc. ($MPLT) on May 07, 2026.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 721 | $28.28 | 242,729.0000 | 45,373,033 | 0.30% | 0.00% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 9250 | $27.50 | 285,907.0000 | 45,373,033 | 3.13% | 0.02% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 5526 | $28.37 | 280,381.0000 | 45,373,033 | 1.93% | 0.01% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 320 | $29.56 | 280,061.0000 | 45,373,033 | 0.11% | 0.00% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 705 | $30.08 | 279,356.0000 | 45,373,033 | 0.25% | 0.00% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 10132 | $28.12 | 269,224.0000 | 45,373,033 | 3.63% | 0.02% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 963 | $29.00 | 268,261.0000 | 45,373,033 | 0.36% | 0.00% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 8390 | $28.04 | 259,871.0000 | 45,373,033 | 3.13% | 0.02% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 16421 | $29.13 | 243,450.0000 | 45,373,033 | 6.32% | 0.04% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 2097 | $27.49 | 295,157.0000 | 45,373,033 | 0.71% | 0.00% |
| April 15, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 1730 | $26.82 | 297,940.0000 | 45,373,033 | 0.58% | 0.00% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 686 | $27.01 | 297,254.0000 | 45,373,033 | 0.23% | 0.00% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 7730 | $0.00 | 298,862.0000 | 45,373,033 | 2.66% | 0.02% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 31395 | $0.00 | 31,395.0000 | 45,373,033 | 9999.99% | 0.07% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | F | Voting Common Stock | 45055 | $17.98 | 291,132.0000 | 45,373,033 | 13.40% | 0.10% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 32539 | $0.00 | 32,539.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 132023 | $0.00 | 132,023.0000 | 0 | 9999.99% | 0.00% |